LOOMIS SAYLES & CO L P - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$81,314
-32.6%
2,129,204
+0.4%
0.14%
-41.7%
Q4 2022$120,660
-99.9%
2,120,571
-1.3%
0.24%
+40.7%
Q3 2022$84,943,000
-11.1%
2,148,273
-1.1%
0.17%
-2.8%
Q2 2022$95,590,000
+9.7%
2,172,478
-0.6%
0.18%
+52.6%
Q1 2022$87,149,000
+12.4%
2,185,274
+13.4%
0.12%
+23.4%
Q4 2021$77,514,000
-3.3%
1,927,738
-2.1%
0.09%
-5.1%
Q3 2021$80,141,000
-10.6%
1,970,055
-0.3%
0.10%
-9.2%
Q2 2021$89,693,000
+8.6%
1,975,194
-0.3%
0.11%
+1.9%
Q1 2021$82,599,000
-2.6%
1,981,256
-0.2%
0.11%
-4.5%
Q4 2020$84,781,000
+123.0%
1,985,026
+37.2%
0.11%
+103.6%
Q3 2020$38,024,000
-0.1%
1,446,855
+1.9%
0.06%
-9.8%
Q2 2020$38,052,000
+63.2%
1,419,336
+9.5%
0.06%
+27.1%
Q1 2020$23,315,000
+2.1%
1,296,003
+0.6%
0.05%
+23.1%
Q4 2019$22,835,000
+13.9%
1,287,945
-0.3%
0.04%0.0%
Q3 2019$20,041,0001,292,1630.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,084,118$61,686,2857.80%
SNYDER CAPITAL MANAGEMENT L P 3,983,814$226,679,0175.12%
First Light Asset Management, LLC 923,119$52,525,4714.88%
Redwood Investments, LLC 441,809$25,138,9323.37%
BERNZOTT CAPITAL ADVISORS 444,728$25,305,0233.27%
DOHENY ASSET MANAGEMENT /CA 46,050$2,6203.04%
Crawford Lake Capital Management, LLC 42,171$2,399,5302.75%
2Xideas AG 416,586$23,703,7432.51%
Granite Investment Partners, LLC 902,882$51,373,9862.14%
HighMark Wealth Management LLC 41,790$2,377,8511.79%
View complete list of HALOZYME THERAPEUTICS INC shareholders